Drug Type Small molecule drug |
Synonyms NVX-412 |
Target |
Action inhibitors |
Mechanism Protein kinases inhibitors |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H13FN6O5 |
InChIKeyACWWGXWLUWFNGY-UHFFFAOYSA-N |
CAS Registry1190062-51-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | Austria | 13 Sep 2012 | |
Melanoma | Discovery | United States | - |